resveratrol has been researched along with Cancer Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Hao, M; Li, M; Li, Y; Tang, Q; Wang, B; Xie, M; Zhu, H | 1 |
| Ding, J; Jiao, M; Liang, J; Liu, T; Tang, Q; Wu, J; Zhu, H | 1 |
| Constandil, L; Flores, C; Hernandez, A; Kogan, MJ; Lespay-Rebolledo, C; Lobos, N; Lux, S; Pelissier, T; Pinto, M; Salas-Huenuleo, E | 1 |
3 other study(ies) available for resveratrol and Cancer Pain
| Article | Year |
|---|---|
Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling.
Topics: AMP-Activated Protein Kinases; Animals; Astrocytes; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Dynamins; Female; Hyperalgesia; Inflammation; Mitochondria; Mitochondrial Dynamics; Osteosarcoma; Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Spinal Cord | 2020 |
Resveratrol attenuates bone cancer pain through regulating the expression levels of ASIC3 and activating cell autophagy.
Topics: Acid Sensing Ion Channels; AMP-Activated Protein Kinases; Animals; Autophagy; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Female; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2017 |
The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat.
Topics: Analgesics; Animals; Behavior, Animal; Bone Neoplasms; Cancer Pain; Carbazoles; Cell Line, Tumor; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred BALB C; Resveratrol; Sirtuin 1 | 2019 |